Milestone Scientific Inc. (NYSE:MLSS – Get Free Report)’s share price was up 2% during trading on Friday . The stock traded as high as $0.4030 and last traded at $0.3990. 125,254 shares were traded during trading, a decline of 88% from the average daily volume of 1,027,132 shares. The stock had previously closed at $0.3911.
Milestone Scientific Stock Performance
The firm has a market capitalization of $35.29 million, a P/E ratio of -5.70 and a beta of 1.05. The company has a 50-day moving average price of $0.37 and a 200-day moving average price of $0.32.
Hedge Funds Weigh In On Milestone Scientific
An institutional investor recently raised its stake in Milestone Scientific stock. Raymond James Financial Inc. raised its stake in shares of Milestone Scientific Inc. (NYSE:MLSS – Free Report) by 416.7% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 62,000 shares of the company’s stock after buying an additional 50,000 shares during the quarter. Raymond James Financial Inc. owned about 0.08% of Milestone Scientific worth $39,000 at the end of the most recent reporting period. Institutional investors own 5.79% of the company’s stock.
Milestone Scientific Company Profile
Milestone Scientific, Inc, listed on the New York Stock Exchange under the symbol MLSS, is a medical device company specializing in the development and commercialization of computer-controlled injection technologies for local anesthesia and pain management. The company’s proprietary systems are designed to enhance patient comfort, improve clinical outcomes and streamline the administration of anesthetics in dental and medical procedures. Through its precision delivery platforms, Milestone Scientific aims to set a new standard for minimally invasive injections.
At the core of Milestone Scientific’s product portfolio is the Single Tooth Anesthesia (STA) System, which uses Comunication Controlled Local Anesthetic Delivery (CCLAD) technology to provide targeted, atraumatic anesthesia for individual dental roots.
See Also
- Five stocks we like better than Milestone Scientific
- Chevron’s Strong Quarter Shows Why It Still Leads the Energy Sector
- Amazon’s Earnings Beat Shows Why AWS Is Back at the Center of the Bull Case
- Apple’s Record Quarter Could Not Outrun Its Guidance Problem
- McKesson’s Compounding Keeps Adding Up
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
